NXTM - Nxstage Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.86B
Enterprise Value 31.79B
Trailing P/E N/A
Forward P/E 1471.50
PEG Ratio (5 yr expected) 1-23.57
Price/Sales (ttm)4.47
Price/Book (mrq)8.54
Enterprise Value/Revenue 34.31
Enterprise Value/EBITDA 6116.78

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin -3.56%
Operating Margin (ttm)-1.09%

Management Effectiveness

Return on Assets (ttm)-0.85%
Return on Equity (ttm)-6.96%

Income Statement

Revenue (ttm)415.16M
Revenue Per Share (ttm)6.26
Quarterly Revenue Growth (yoy)11.20%
Gross Profit (ttm)168.59M
EBITDA 15.33M
Net Income Avi to Common (ttm)-15.24M
Diluted EPS (ttm)-0.23
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)76.29M
Total Cash Per Share (mrq)1.16
Total Debt (mrq)13.47M
Total Debt/Equity (mrq)6.09
Current Ratio (mrq)3.36
Book Value Per Share (mrq)3.31

Cash Flow Statement

Operating Cash Flow (ttm)17.89M
Levered Free Cash Flow (ttm)38.84M

Trading Information

Stock Price History

Beta 0.66
52-Week Change 33.65%
S&P500 52-Week Change 315.86%
52 Week High 328.75
52 Week Low 322.70
50-Day Moving Average 328.27
200-Day Moving Average 326.98

Share Statistics

Avg Vol (3 month) 3397.82k
Avg Vol (10 day) 3358.38k
Shares Outstanding 565.58M
Float 53.95M
% Held by Insiders 12.13%
% Held by Institutions 188.37%
Shares Short (Aug 31, 2018) 42.48M
Short Ratio (Aug 31, 2018) 47.44
Short % of Float (Aug 31, 2018) 43.81%
Short % of Shares Outstanding (Aug 31, 2018) 43.78%
Shares Short (prior month Jul 31, 2018) 42.63M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A